等待開盤 01-28 09:30:00 美东时间
-0.190
-0.41%
今日重点评级关注:HC Wainwright & Co.:维持NioCorp Developments"买入"评级,目标价从9.5美元升至11.25美元;摩根士丹利:维持Chewy"超配"评级,目标价从48美元升至51美元
01-14 11:25
Wells Fargo analyst Elyse Greenspan maintains Equitable Holdings (NYSE:EQH) with a Overweight and lowers the price target from $62 to $60.
01-13 22:42
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
JP Morgan analyst Jimmy Bhullar upgrades Equitable Holdings (NYSE:EQH) from Neutral to Overweight and lowers the price target from $64 to $60.
01-05 20:26
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
2025-12-17 10:46
Mizuho analyst Yaron Kinar initiates coverage on Equitable Holdings (NYSE:EQH) with a Outperform rating and announces Price Target of $66.
2025-12-16 21:11
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 10:22
Wells Fargo analyst Elyse Greenspan maintains Equitable Holdings (NYSE:EQH) with a Overweight and lowers the price target from $65 to $62.
2025-11-08 02:38